Exposure to light at night accelerates aging and spontaneous uterine carcinogenesis in female 129/Sv mice.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3713136)

Published in Cell Cycle on May 06, 2013

Authors

Irina G Popovich1, Mark A Zabezhinski, Andrei V Panchenko, Tatiana S Piskunova, Anna V Semenchenko, Maragriata L Tyndyk, Maria N Yurova, Vladimir N Anisimov

Author Affiliations

1: Laboratory of Carcinogenesis and Aging, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia.

Articles cited by this

Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet (2005) 6.87

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33

Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60

Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst (2003) 2.87

Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol (2009) 2.40

Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med (2012) 1.98

Circadian clock proteins control adaptation to novel environment and memory formation. Aging (Albany NY) (2010) 1.95

The circadian clock and pathology of the ageing brain. Nat Rev Neurosci (2012) 1.90

Circadian clock protein BMAL1 regulates cellular senescence in vivo. Cell Cycle (2011) 1.87

Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum (2010) 1.66

Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) (2011) 1.61

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60

Metformin for aging and cancer prevention. Aging (Albany NY) (2010) 1.51

Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int (2009) 1.40

Circadian rhythm disruption in cancer biology. Mol Med (2012) 1.31

Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control (2010) 1.27

Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY) (2010) 1.19

Melatonin and mammary cancer: a short review. Endocr Relat Cancer (2003) 1.03

Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta (2006) 0.97

Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging (Albany NY) (2009) 0.97

Methods of evaluating the effect of pharmacological drugs on aging and life span in mice. Methods Mol Biol (2007) 0.97

Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res (2003) 0.95

A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ (2006) 0.94

Hypothalmic mechanisms of ageing and of specific age pathology--I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol (1979) 0.91

The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci (1999) 0.90

Aging and circadian disruption: causes and effects. Aging (Albany NY) (2011) 0.89

Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res (2004) 0.86

Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett (2006) 0.86

Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis (1997) 0.85

The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol (2003) 0.85

The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocrinol Lett (2001) 0.84

The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer (2003) 0.84

[Effect of different light regimens on the development of metabolic syndrome of aging rats]. Adv Gerontol (2007) 0.79

Light-at-night, cancer and aging. Aging (Albany NY) (2010) 0.78

Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett (2001) 0.78

[Colon carcinogenesis in rat vs. variable light]. Vopr Onkol (2008) 0.76

Articles by these authors

Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle (2011) 5.42

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol (2005) 3.06

Metformin slows down aging and extends life span of female SHR mice. Cell Cycle (2008) 2.77

Rapamycin extends maximal lifespan in cancer-prone mice. Am J Pathol (2010) 2.22

An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta (2008) 1.70

If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY) (2011) 1.61

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle (2010) 1.45

Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging (Albany NY) (2010) 1.22

Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology (2003) 1.17

Deficiency in Poly(ADP-ribose) Polymerase-1 (PARP-1) Accelerates Aging and Spontaneous Carcinogenesis in Mice. Curr Gerontol Geriatr Res (2008) 1.06

Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging (Albany NY) (2011) 0.97

Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta (2006) 0.97

Methods of evaluating the effect of pharmacological drugs on aging and life span in mice. Methods Mol Biol (2007) 0.97

Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging (Albany NY) (2009) 0.97

Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. Int J Cancer (2004) 0.95

Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer. Aging (Albany NY) (2013) 0.94

Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice. Cancer Lett (2003) 0.93

Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice? Exp Gerontol (2004) 0.88

The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer (2003) 0.84

Effects of phentermine and phenformin on biomarkers of aging in rats. Gerontology (2004) 0.83

Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens. Ann N Y Acad Sci (2005) 0.83

Light-at-night-induced circadian disruption, cancer and aging. Curr Aging Sci (2012) 0.83

Body weight is not always a good predictor of longevity in mice. Exp Gerontol (2004) 0.81

Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in young but not in old rats. Aging (Albany NY) (2010) 0.81

Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen. Int J Biochem Cell Biol (2005) 0.81

Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin. Cell Cycle (2015) 0.79

Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging. Expert Opin Drug Discov (2011) 0.79

Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice. Exp Gerontol (2003) 0.79

Multifaceted aging and rapamycin. Aging (Albany NY) (2013) 0.78

Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology (2003) 0.78

Methods of testing pharmacological drugs effects on aging and life span in mice. Methods Mol Biol (2013) 0.78

Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int J Cancer (2002) 0.77

Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice. Mech Ageing Dev (2003) 0.76

A model of accelerated aging induced by 5-bromodeoxyuridine. Biogerontology (2002) 0.75

Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. In Vivo (2006) 0.75

Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Lett (2002) 0.75

Light, endocrine systems and cancer--a meeting report. Neuro Endocrinol Lett (2002) 0.75

Physiological and Biochemical Mechanisms of Lifespan Regulation in Rats Kept Under Various Light Conditions. Curr Aging Sci (2017) 0.75

Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. Neuro Endocrinol Lett (2004) 0.75